Fredun Pharmaceuticals Unveils Cellular Longevity Dedicated Platform ‘Daulcél’
Mumbai (Maharashtra) [India], May 18: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), has announced the launch of ‘DAULCÉL’, its premium wellness and longevity-focused brand developed to cater to the growing demand for preventive healthcare, healthy aging, and lifestyle-oriented wellness solutions. The launch marks another strategic step in Fredun’s expansion into innovation-led and future-focused healthcare […]
Continue Reading